Multiplex Detection Immunoassays Market (By Assay Type: Planar Assay, Bead-based Assay; By Technique: Nucleic Acid-based Techniques, Protein-based Techniques, Biosensor-based Techniques; By Application: Disease Testing, Food Contamination Testing, R&D, Veterinary Disease Testing; By End User) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2021-2030

Chapter 1.  Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.  Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.  Executive Summary

3.1.  Market Snapshot

Chapter 4.  Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.    Raw Material Procurement Analysis

4.3.2.    Sales and Distribution Channel Analysis

4.3.3.    Downstream Buyer Analysis

Chapter 5.  Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.    Market Drivers

5.1.2.    Market Restraints

5.1.3.    Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.    Bargaining power of suppliers

5.2.2.    Bargaining power of buyers

5.2.3.    Threat of substitute

5.2.4.    Threat of new entrants

5.2.5.    Degree of competition

Chapter 6.  Competitive Landscape

6.1.1.    Company Market Share/Positioning Analysis

6.1.2.    Key Strategies Adopted by Players

6.1.3.    Vendor Landscape

6.1.3.1.        List of Suppliers

6.1.3.2.        List of Buyers

Chapter 7.  Global Multiplex Detection Immunoassays Market, By Assay Type

7.1.  Multiplex Detection Immunoassays Market, by Assay Type, 2021-2030

7.1.1.    Planar Assay

7.1.1.1.        Market Revenue and Forecast (2017-2030)

7.1.2.    Blends Protein Arrays (Multiplexed ELISA)

7.1.2.1.        Market Revenue and Forecast (2017-2030)

7.1.3.    Antibody Arrays

7.1.3.1.        Market Revenue and Forecast (2017-2030)

7.1.4.    Bead-based Assay

7.1.4.1.        Market Revenue and Forecast (2017-2030)

7.1.5.    Magnetic Bead-based

7.1.5.1.        Market Revenue and Forecast (2017-2030)

7.1.6.    Non-magnetic Bead-based

7.1.6.1.        Market Revenue and Forecast (2017-2030)

Chapter 8.  Global Multiplex Detection Immunoassays Market, By Technique

8.1.  Multiplex Detection Immunoassays Market, by Technique, 2021-2030

8.1.1.    Nucleic Acid-based Techniques

8.1.1.1.        Market Revenue and Forecast (2017-2030)

8.1.2.    Protein-based Techniques

8.1.2.1.        Market Revenue and Forecast (2017-2030)

8.1.3.    Biosensor-based Techniques

8.1.3.1.        Market Revenue and Forecast (2017-2030)

Chapter 9.  Global Multiplex Detection Immunoassays Market, By Application

9.1.  Multiplex Detection Immunoassays Market, by Application, 2021-2030

9.1.1.    Disease Testing

9.1.1.1.        Market Revenue and Forecast (2017-2030)

9.1.2.    Infectious Disease Testing

9.1.2.1.        Market Revenue and Forecast (2017-2030)

9.1.3.    Autoimmune Disease Testing

9.1.3.1.        Market Revenue and Forecast (2017-2030)

9.1.4.    Other Diseases Testing

9.1.4.1.        Market Revenue and Forecast (2017-2030)

9.1.5.    Food Contamination Testing

9.1.5.1.        Market Revenue and Forecast (2017-2030)

9.1.6.    Research & Development

9.1.6.1.        Market Revenue and Forecast (2017-2030)

9.1.7.    Veterinary Disease Testing

9.1.7.1.        Market Revenue and Forecast (2017-2030)

Chapter 10.      Global Multiplex Detection Immunoassays Market, By End User

10.1.        Multiplex Detection Immunoassays Market, by End User, 2021-2030

10.1.1.  Pharmaceutical & Biopharmaceutical Companies

10.1.1.1.      Market Revenue and Forecast (2017-2030)

10.1.2.  Clinical Research Organizations

10.1.2.1.      Market Revenue and Forecast (2017-2030)

10.1.3.  Food & Beverages Industry

10.1.3.1.      Market Revenue and Forecast (2017-2030)

10.1.4.  Academic & Research Institutes

10.1.4.1.      Market Revenue and Forecast (2017-2030)

10.1.5.  Diagnostic Centers

10.1.5.1.      Market Revenue and Forecast (2017-2030)

10.1.6.  Others

10.1.6.1.      Market Revenue and Forecast (2017-2030)

Chapter 11.      Global Multiplex Detection Immunoassays Market, Regional Estimates and Trend Forecast

11.1.        North America

11.1.1.  Market Revenue and Forecast, by Assay Type (2017-2030)

11.1.2.  Market Revenue and Forecast, by Technique (2017-2030)

11.1.3.  Market Revenue and Forecast, by Application (2017-2030)

11.1.4.  Market Revenue and Forecast, by End User (2017-2030)

11.1.5.  U.S.

11.1.5.1.      Market Revenue and Forecast, by Assay Type (2017-2030)

11.1.5.2.      Market Revenue and Forecast, by Technique (2017-2030)

11.1.5.3.      Market Revenue and Forecast, by Application (2017-2030)

11.1.5.4.      Market Revenue and Forecast, by End User (2017-2030)

11.1.6.  Rest of North America

11.1.6.1.      Market Revenue and Forecast, by Assay Type (2017-2030)

11.1.6.2.      Market Revenue and Forecast, by Technique (2017-2030)

11.1.6.3.      Market Revenue and Forecast, by Application (2017-2030)

11.1.6.4.      Market Revenue and Forecast, by End User (2017-2030)

11.2.        Europe

11.2.1.  Market Revenue and Forecast, by Assay Type (2017-2030)

11.2.2.  Market Revenue and Forecast, by Technique (2017-2030)

11.2.3.  Market Revenue and Forecast, by Application (2017-2030)

11.2.4.  Market Revenue and Forecast, by End User (2017-2030)

11.2.5.  UK

11.2.5.1.      Market Revenue and Forecast, by Assay Type (2017-2030)

11.2.5.2.      Market Revenue and Forecast, by Technique (2017-2030)

11.2.5.3.      Market Revenue and Forecast, by Application (2017-2030)

11.2.5.4.      Market Revenue and Forecast, by End User (2017-2030)

11.2.6.  Germany

11.2.6.1.      Market Revenue and Forecast, by Assay Type (2017-2030)

11.2.6.2.      Market Revenue and Forecast, by Technique (2017-2030)

11.2.6.3.      Market Revenue and Forecast, by Application (2017-2030)

11.2.6.4.      Market Revenue and Forecast, by End User (2017-2030)

11.2.7.  France

11.2.7.1.      Market Revenue and Forecast, by Assay Type (2017-2030)

11.2.7.2.      Market Revenue and Forecast, by Technique (2017-2030)

11.2.7.3.      Market Revenue and Forecast, by Application (2017-2030)

11.2.7.4.      Market Revenue and Forecast, by End User (2017-2030)

11.2.8.  Rest of Europe

11.2.8.1.      Market Revenue and Forecast, by Assay Type (2017-2030)

11.2.8.2.      Market Revenue and Forecast, by Technique (2017-2030)

11.2.8.3.      Market Revenue and Forecast, by Application (2017-2030)

11.2.8.4.      Market Revenue and Forecast, by End User (2017-2030)

11.3.        APAC

11.3.1.  Market Revenue and Forecast, by Assay Type (2017-2030)

11.3.2.  Market Revenue and Forecast, by Technique (2017-2030)

11.3.3.  Market Revenue and Forecast, by Application (2017-2030)

11.3.4.  Market Revenue and Forecast, by End User (2017-2030)

11.3.5.  India

11.3.5.1.      Market Revenue and Forecast, by Assay Type (2017-2030)

11.3.5.2.      Market Revenue and Forecast, by Technique (2017-2030)

11.3.5.3.      Market Revenue and Forecast, by Application (2017-2030)

11.3.5.4.      Market Revenue and Forecast, by End User (2017-2030)

11.3.6.  China

11.3.6.1.      Market Revenue and Forecast, by Assay Type (2017-2030)

11.3.6.2.      Market Revenue and Forecast, by Technique (2017-2030)

11.3.6.3.      Market Revenue and Forecast, by Application (2017-2030)

11.3.6.4.      Market Revenue and Forecast, by End User (2017-2030)

11.3.7.  Japan

11.3.7.1.      Market Revenue and Forecast, by Assay Type (2017-2030)

11.3.7.2.      Market Revenue and Forecast, by Technique (2017-2030)

11.3.7.3.      Market Revenue and Forecast, by Application (2017-2030)

11.3.7.4.      Market Revenue and Forecast, by End User (2017-2030)

11.3.8.  Rest of APAC

11.3.8.1.      Market Revenue and Forecast, by Assay Type (2017-2030)

11.3.8.2.      Market Revenue and Forecast, by Technique (2017-2030)

11.3.8.3.      Market Revenue and Forecast, by Application (2017-2030)

11.3.8.4.      Market Revenue and Forecast, by End User (2017-2030)

11.4.        MEA

11.4.1.  Market Revenue and Forecast, by Assay Type (2017-2030)

11.4.2.  Market Revenue and Forecast, by Technique (2017-2030)

11.4.3.  Market Revenue and Forecast, by Application (2017-2030)

11.4.4.  Market Revenue and Forecast, by End User (2017-2030)

11.4.5.  GCC

11.4.5.1.      Market Revenue and Forecast, by Assay Type (2017-2030)

11.4.5.2.      Market Revenue and Forecast, by Technique (2017-2030)

11.4.5.3.      Market Revenue and Forecast, by Application (2017-2030)

11.4.5.4.      Market Revenue and Forecast, by End User (2017-2030)

11.4.6.  North Africa

11.4.6.1.      Market Revenue and Forecast, by Assay Type (2017-2030)

11.4.6.2.      Market Revenue and Forecast, by Technique (2017-2030)

11.4.6.3.      Market Revenue and Forecast, by Application (2017-2030)

11.4.6.4.      Market Revenue and Forecast, by End User (2017-2030)

11.4.7.  South Africa

11.4.7.1.      Market Revenue and Forecast, by Assay Type (2017-2030)

11.4.7.2.      Market Revenue and Forecast, by Technique (2017-2030)

11.4.7.3.      Market Revenue and Forecast, by Application (2017-2030)

11.4.7.4.      Market Revenue and Forecast, by End User (2017-2030)

11.4.8.  Rest of MEA

11.4.8.1.      Market Revenue and Forecast, by Assay Type (2017-2030)

11.4.8.2.      Market Revenue and Forecast, by Technique (2017-2030)

11.4.8.3.      Market Revenue and Forecast, by Application (2017-2030)

11.4.8.4.      Market Revenue and Forecast, by End User (2017-2030)

11.5.        Latin America

11.5.1.  Market Revenue and Forecast, by Assay Type (2017-2030)

11.5.2.  Market Revenue and Forecast, by Technique (2017-2030)

11.5.3.  Market Revenue and Forecast, by Application (2017-2030)

11.5.4.  Market Revenue and Forecast, by End User (2017-2030)

11.5.5.  Brazil

11.5.5.1.      Market Revenue and Forecast, by Assay Type (2017-2030)

11.5.5.2.      Market Revenue and Forecast, by Technique (2017-2030)

11.5.5.3.      Market Revenue and Forecast, by Application (2017-2030)

11.5.5.4.      Market Revenue and Forecast, by End User (2017-2030)

11.5.6.  Rest of LATAM

11.5.6.1.      Market Revenue and Forecast, by Assay Type (2017-2030)

11.5.6.2.      Market Revenue and Forecast, by Technique (2017-2030)

11.5.6.3.      Market Revenue and Forecast, by Application (2017-2030)

11.5.6.4.      Market Revenue and Forecast, by End User (2017-2030)

Chapter 12.  Company Profiles

12.1.              Hoffmann-La Roche Ltd.

12.1.1.  Company Overview

12.1.2.  Product Offerings

12.1.3.  Financial Performance

12.1.4.  Recent Initiatives

12.2.              QIAGEN

12.2.1.  Company Overview

12.2.2.  Product Offerings

12.2.3.  Financial Performance

12.2.4.  Recent Initiatives

12.3.              Merck KGaA

12.3.1.  Company Overview

12.3.2.  Product Offerings

12.3.3.  Financial Performance

12.3.4.  Recent Initiatives

12.4.              Microsynth AG

12.4.1.  Company Overview

12.4.2.  Product Offerings

12.4.3.  Financial Performance

12.4.4.  Recent Initiatives

12.5.              Bio-Rad Laboratories

12.5.1.  Company Overview

12.5.2.  Product Offerings

12.5.3.  Financial Performance

12.5.4.  Recent Initiatives

12.6.              Thermo Fisher

12.6.1.  Company Overview

12.6.2.  Product Offerings

12.6.3.  Financial Performance

12.6.4.  Recent Initiatives

12.7.              Luminex Corporation

12.7.1.  Company Overview

12.7.2.  Product Offerings

12.7.3.  Financial Performance

12.7.4.  Recent Initiatives

12.8.              Becton

12.8.1.  Company Overview

12.8.2.  Product Offerings

12.8.3.  Financial Performance

12.8.4.  Recent Initiatives

12.9.              Dickinson and Company

12.9.1.  Company Overview

12.9.2.  Product Offerings

12.9.3.  Financial Performance

12.9.4.  Recent Initiatives

Chapter 13.  Research Methodology

13.1.              Primary Research

13.2.              Secondary Research

13.3.              Assumptions

Chapter 14.  Appendix

14.1.              About Us

Glossary of Terms

Report Details

  • Report Code:38200
  • Category:Healthcare
  • No. of Pages:150+
  • Format:PDF/PPT/Excel
  • Published:July 2021
  • Historical Year:2021-2022
  • Base Year:2023
  • Estimated Year:2024-2033

Proceed To Buy

USD 4500
USD 3800
USD 1900
USD 1200

Customization Offered

  • check-imgCross-segment Market Size and Analysis for Mentioned Segments
  • check-imgAdditional Company Profiles (Upto 5 With No Cost)
  • check-img Additional Countries (Apart From Mentioned Countries)
  • check-img Country/Region-specific Report
  • check-img Go To Market Strategy
  • check-imgRegion Specific Market Dynamics
  • check-imgRegion Level Market Share
  • check-img Import Export Analysis
  • check-imgProduction Analysis
  • check-imgOthers